Related Experiment Video
Updated: May 19, 2026
08:39
Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
Liver transplantation and hepatitis C.
Nobuhisa Akamatsu1, Yasuhiko Sugawara
1Department of Hepato-Biliary-Pancreatic Surgery, Saitama Medical Center, Saitama Medical University, 1981 Tsujido-cho, Kamoda, Kawagoe, Saitama 350-8550, Japan.
International Journal of Hepatology
|August 18, 2012
Summary
Hepatitis C virus (HCV) reinfection after liver transplant leads to graft failure. Monitoring and timely antiviral treatment are crucial for improving outcomes in HCV-cirrhosis patients undergoing liver transplantation.
Area of Science:
- Hepatology
- Transplantation Immunology
- Virology
Background:
- Hepatitis C virus (HCV)-related end-stage cirrhosis is a leading cause for liver transplantation.
- HCV reinfection post-transplant is universal, causing fibrosis, cirrhosis, and graft decompensation.
- Organ quality, especially from older donors, negatively impacts recurrence and survival.
Purpose of the Study:
- To review current understanding of HCV recurrence after liver transplantation.
- To discuss the impact of immunosuppression and organ quality on outcomes.
- To evaluate monitoring strategies and antiviral treatments for HCV recurrence.
Main Methods:
- Literature review of studies on liver transplantation for HCV cirrhosis.
- Analysis of factors influencing HCV recurrence and graft survival.
- Evaluation of current and emerging treatment strategies for post-transplant HCV.
Main Results:
- Graft reinfection with HCV is inevitable post-transplantation, leading to graft failure.
- Immunosuppression and organ quality significantly affect recurrence severity and survival.
- Pegylated interferon and ribavirin show limited efficacy (30-35% sustained viral response).
- Living-donor liver transplantation offers outcomes comparable to deceased-donor transplantation.
Conclusions:
- Close monitoring and timely antiviral therapy are essential for managing HCV recurrence.
- Optimal immunosuppressive regimens and organ selection criteria require further investigation.
- HCV cirrhosis remains a significant challenge in liver transplantation, necessitating ongoing research into effective treatments and prevention strategies.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:24Liver Regeneration
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...